Related Experiment Videos
Improving the management of hypertension in clinical practice
1Cattedra di Medicina Interna, University of Milan, Ospedale San Gerardo, Monza, Italy.
Insights
Optimizing antihypertensive therapy is crucial for reducing cardiovascular risk. Improving blood pressure control, managing other conditions, and enhancing patient adherence can lead to better outcomes in hypertension management.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Antihypertensive therapy offers proven benefits but current treatments do not fully normalize cardiovascular risk.
- Hypertension management requires a comprehensive approach beyond simple blood pressure reduction.
Purpose of the Study:
- To explore strategies for improving the management of hypertension and reducing associated cardiovascular risk.
- To identify key factors influencing therapeutic outcomes in hypertensive patients.
Main Methods:
- Review of current antihypertensive treatment guidelines and clinical practices.
- Analysis of factors affecting blood pressure control and patient outcomes.
- Consideration of concomitant disease management and risk factor modification.
Main Results:
- Effective hypertension management requires control of both systolic (SBP) and diastolic blood pressure (DBP) to below 140/90 mmHg.
- Addressing co-existing diseases and other cardiovascular risk factors is beneficial.
- 24-hour blood pressure control and understanding blood pressure variability are important, though treatment impact on variability is unclear.
- Patient compliance significantly impacts treatment success and may be improved by simpler regimens.
Conclusions:
- Current antihypertensive strategies can be enhanced through multifaceted approaches.
- Optimizing blood pressure targets, managing comorbidities, and improving patient adherence are key to reducing cardiovascular risk in hypertensive individuals.
Abstract:
Antihypertensive therapy is unquestionably beneficial, but current management of hypertension does not reduce cardiovascular risk to normotensive levels. Treatment of the hypertensive patient may be improved by a number of measures. These include control of SBP as well as DBP, with reduction to < 140/90 mmHg. Treatment of concomitant diseases and of other risk factors is likely to be of benefit, as is 24 h control of BP. Variability of BP appears to influence clinical outcome, but it is unclear whether this can be reduced by treatment. Poor patient compliance with treatment instructions may be an important factor in disappointing therapeutic performance, but could be improved with less complex treatment regimens.